MedTech Resources

Reimbursement Pathway Explorer

How new technology gets paid for

FDA authorization lets a device be sold. Whether it gets used depends on who pays for it. This page tracks the steps that follow: Medicare's national and local coverage decisions, straight from CMS, and a plain-language guide to the payment and coding pathways a new technology goes through.

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026Source: CMS Medicare Coverage DatabaseMethods & limitations

Filter

Reset

Fiscal year means Medicare's year, which starts on October 1. It is the year of a document's latest change. Specialty is matched on words in the title, so it is approximate.

Coverage documents

1,674

National and local, from CMS

Changed in the last 30 days

70

By CMS's last-updated date

Open or proposed

101

National analyses under review and draft local determinations

National

644

Determinations and analyses. 1,030 local.

Recently changed Medicare coverage

National coverage determinations and analyses, and final and proposed local coverage determinations, newest change first. Each title opens the CMS record.

UpdatedDocumentTypeStatus
Nov 19, 2026Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer

CAG-00422N · New

GI, Urology & NephrologyUrology

National analysisReview closed
Nov 19, 2026Artificial Hearts and related devices, including Ventricular Assist Devices for Bridge-to-Transplant and Destination Therapy

CAG-00453N · New

CardiologyInterventional Cardiology

National analysisReview closed
Nov 19, 2026Aprepitant for Chemotherapy-Induced Emesis

CAG-00248R · 1st Recon

National analysisReview closed
Nov 19, 2026Anticancer Chemotherapy for Colorectal Cancer

CAG-00179N · New

National analysisReview closed
Nov 19, 2026Ambulatory Blood Pressure Monitoring (ABPM)

CAG-00067R2 · 2nd Recon

National analysisReview closed
Nov 19, 2026Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndromes (MDS)

CAG-00415R · 1st Recon

National analysisReview closed
Nov 19, 2026Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Myelodysplastic Syndrome

CAG-00415N · New

National analysisReview closed
Nov 19, 2026Acupuncture for Nausea after Chemotherapy and Post-operative Pain

CAG-00062N · New

National analysisReview closed
Nov 19, 2026Actinic Keratoses

CAG-00049N · New

National analysisReview closed
Nov 18, 2026Hyperbaric Oxygen Therapy for Chronic Radiation Induced Proctitis and Enteritis

CAG-00060R2 · 2nd Recon

CMS note: Posted new tracking sheet.

Radiology & ImagingAnesthesiology & Respiratory

National analysisReview closed
Nov 18, 2026Leadless CRT - Wireless Stimulation Endocardially (WiSE)

CAG-00471N · New

CMS note: Posted proposed decision memo.

CardiologyNeuromodulation

National analysisReview closed
Nov 18, 2026Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy System (WiSE CRT)

CAG-00471N · New

CMS note: Posted proposed decision memo.

CardiologyNeuromodulation

National analysisReview closed
Nov 10, 2026Magnetic Resonance Imaging of the Head and Neck

L34425 · Palmetto GBA · Effective Nov 19, 2026

Radiology & Imaging

Local determinationIn effect
Nov 9, 2026Retroperitoneal Ultrasound

L34577 · Palmetto GBA · Effective Nov 19, 2026

Radiology & Imaging

Local determinationIn effect
Nov 6, 2026MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer

L38284 · CGS Administrators, LLC · Effective Nov 12, 2026

Anesthesiology & RespiratoryOtolaryngology (ENT)Pulmonology

Local determinationIn effect
Nov 5, 2026ProMark® Risk Score

L36675 · CGS Administrators, LLC · Effective Nov 12, 2026

Local determinationIn effect
Nov 5, 2026Laboratory Tests - CRD Patients

190.10

Laboratory Medicine & Pathology

National determinationOn the books
Nov 5, 2026Percutaneous Image-Guided Lumbar Decompression for Lumbar Spinal Stenosis

150.13

Orthopedic SurgeryInterventional CardiologySpine

National determinationOn the books
Nov 5, 2026Wrong Surgical or Other Invasive Procedure Performed on a Patient

140.6

General & Plastic Surgery

National determinationOn the books
Nov 5, 2026External Infusion Pumps

L33794 · CGS Administrators, LLC · Effective Oct 1, 2026

Hospital Medicine & Nursing

Local determinationIn effect
Nov 5, 2026Next Generation Sequencing (NGS)

90.2

CMS note: No policy changes. Updated NCD coding via new Change Request/Transmittal.

Laboratory Medicine & Pathology

National determinationOn the books
Nov 5, 2026Vagus Nerve Stimulation (VNS)

160.18

Neurology & NeurosurgeryNeuromodulation

National determinationOn the books
Nov 4, 2026Positron Emission Tomography (FDG) for Oncologic Conditions

220.6.17

Radiology & Imaging

National determinationOn the books
Nov 4, 2026Percutaneous Left Atrial Appendage Closure (LAAC)

20.34

CardiologyInterventional Cardiology

National determinationOn the books
Nov 4, 2026Ornish Program for Reversing Heart Disease

20.31.2

Cardiology

National determinationOn the books
Page 1 of 67Older

The pathways, in plain language

Coverage is one step. Payment and coding are set through separate CMS and AMA processes, linked below.

  • New technology add-on payment (NTAP)

    Extra Medicare payment to a hospital, on top of the usual inpatient rate, when it uses a new and costly technology. Medicare approves it one fiscal year at a time, usually for two to three years.

    CMS inpatient payment rules
  • Transitional pass-through payment (TPT)

    Separate Medicare payment for a new device used in a hospital outpatient department or surgery center, for two to three years, while Medicare collects cost data to fold the device into its regular rates.

    CMS outpatient payment rules
  • Category III CPT code

    A temporary tracking code for an emerging procedure or service. It lets claims be counted, but it has no assigned physician payment value, so payment is decided payer by payer.

    American Medical Association
  • Category I CPT code

    A permanent procedure code. Moving from a temporary code to a permanent one usually comes with an assigned physician payment value, which is why it is a milestone for a new technology.

    American Medical Association
  • HCPCS Level II code

    A code Medicare issues for products, supplies and services that procedure codes do not cover, such as a specific device or drug. New codes are issued several times a year.

    CMS HCPCS
  • National coverage determination (NCD)

    A nationwide Medicare decision on whether, and for which patients, an item or service is covered. It binds every Medicare contractor.

    Medicare Coverage Database
  • Local coverage determination (LCD)

    A coverage decision made by one of the regional contractors that process Medicare claims. It applies only in that contractor's region, so coverage can differ from state to state.

    Medicare Coverage Database
  • Transitional Coverage for Emerging Technologies (TCET)

    A Medicare pathway meant to shorten the wait between FDA authorization of certain breakthrough devices and a national coverage decision, with coverage tied to collecting more evidence.

    CMS

CPT is a registered trademark of the American Medical Association. Code descriptors belong to the AMA and are not reproduced here. We give our own short summary of each kind of code, with a link to the AMA.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.